FDA Inspection 803242 — Arthrex Inland Empire
The FDA completed an inspection of Arthrex Inland Empire on Oct 16, 2012 in Corona, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 16, 2012
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Corona, CA (United States)